Share:
WILMETTE, Ill., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler D. Robinson, MD, Chief Executive Officer, is planning to present a Company overview at the following investor conferences in March:
H.C. Wainwright Global Life Sciences Conference
The Company's presentation will be webcast on Tuesday, March 9, 2021 at 7:00 a.m. ET
33
Annual Roth Conference, Healthcare
The Company's fireside chat will be webcast on Tuesday, March 16, 2021 at 12:00 p.m. ET
Maxim's 2021 Emerging Growth Virtual Conference